Emend
aprepitant
Vomiting
Postoperative Nausea and Vomiting
Cancer
Date of authorisation:
Revision: 31
Last updated:
MedicineHumanAuthorised
Akynzeo
netupitant
palonosetron
Vomiting
Neoplasms
Nausea
Cancer
Date of authorisation:
Revision: 17
Last updated:
MedicineHumanAuthorised
Palonosetron Hospira
palonosetron
Nausea
Vomiting
Cancer
Date of authorisation:
Revision: 4
Last updated:
MedicineHumanWithdrawn
Palonosetron Accord
palonosetron
Vomiting
Nausea
Cancer
Date of authorisation:
Revision: 5
Last updated:
MedicineHumanAuthorised
EMEA-001198-PIP03-17-M04 - paediatric investigation plan
Decision type: PM: decision on the application for modification of an agreed PIP
Therapeutic area: Other
PIP number: P/0272/2020
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for concentrate for solution for infusion
Concentrate for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
EMEA-001768-PIP02-15-M03 - paediatric investigation plan
Decision type: W: decision granting a waiver in all age groups for all conditions or indications
Therapeutic area: Haematology-Hemostaseology
PIP number: P/0194/2020
Route(s) of administration: Oral use
Pharmaceutical form(s):
Film-coated tablet
Age-appropriate oral dosage form
Decision date:
Last updated:
Compliance check: ✖
PIPHuman
Varuby
rolapitant
Vomiting
Nausea
Cancer
Date of authorisation:
Revision: 3
Last updated:
MedicineHumanWithdrawn
EMEA-001198-PIP02-16 - paediatric investigation plan
Decision type: RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)
Therapeutic area: Other
PIP number: P/0358/2016
Route(s) of administration: Intravenous use
Pharmaceutical form(s):
Powder for solution for infusion
Decision date:
Last updated:
Compliance check: ✖
PIPHuman